CADL vs. QBTS

Last updated Apr 1, 2026

Compare and contrast key facts about Candel Therapeutics, Inc. (CADL) and D-Wave Quantum Inc (QBTS).

Performance

CADL vs. QBTS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Candel Therapeutics, Inc. (CADL) and D-Wave Quantum Inc (QBTS). The values are adjusted to include any dividend payments, if applicable.

CADL vs. QBTS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
CADL Candel Therapeutics, Inc.	-13.27%	-34.91%	490.48%	-17.88%	-47.04%
QBTS D-Wave Quantum Inc	-44.82%	211.31%	854.44%	-38.88%	-85.60%

Fundamentals

Market Cap CADL : $269.00M QBTS : $5.09B
EPS CADL : -$0.16 QBTS : -$1.08
PB Ratio CADL : 5.18 QBTS : 5.98
Total Revenue (TTM) CADL : $0.00 QBTS : $24.59M
Gross Profit (TTM) CADL : -$682.00K QBTS : $20.31M
EBITDA (TTM) CADL : -$23.05M QBTS : -$345.51M

Returns By Period

In the year-to-date period, CADL achieves a -13.27% return, which is significantly higher than QBTS's -44.82% return.

CADL

• 1D: 9.38%
• 1M: -6.67%
• YTD: -13.27%
• 6M: -3.92%
• 1Y: -13.27%
• 3Y*: 53.68%
• 5Y*: —
• 10Y*: —

QBTS

• 1D: 11.17%
• 1M: -23.16%
• YTD: -44.82%
• 6M: -41.60%
• 1Y: 89.87%
• 3Y*: 179.05%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CADL vs. QBTS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CADL

CADL Risk / Return Rank: 31
CADL Sharpe Ratio Rank: 33
CADL Sortino Ratio Rank: 35
CADL Omega Ratio Rank: 34
CADL Calmar Ratio Rank: 27
CADL Martin Ratio Rank: 27

QBTS

QBTS Risk / Return Rank: 71
QBTS Sharpe Ratio Rank: 69
QBTS Sortino Ratio Rank: 80
QBTS Omega Ratio Rank: 71
QBTS Calmar Ratio Rank: 69
QBTS Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CADL vs. QBTS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Candel Therapeutics, Inc. (CADL) and D-Wave Quantum Inc (QBTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CADL	QBTS	Difference
Sharpe ratio Return per unit of total volatility	-0.19	0.77	-0.96
Sortino ratio Return per unit of downside risk	0.23	2.04	-1.82
Omega ratio Gain probability vs. loss probability	1.03	1.22	-0.19
Calmar ratio Return relative to maximum drawdown	-0.47	1.27	-1.75
Martin ratio Return relative to average drawdown	-0.86	2.69	-3.55
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CADL vs. QBTS - Sharpe Ratio Comparison

The current CADL Sharpe Ratio is -0.19, which is lower than the QBTS Sharpe Ratio of 0.77. The chart below compares the historical Sharpe Ratios of CADL and QBTS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CADL	QBTS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.19	0.77	-0.96
Sharpe Ratio (All Time) Calculated using the full available price history	-0.04	0.07	-0.11

Correlation

The correlation between CADL and QBTS is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CADL vs. QBTS - Dividend Comparison

Neither CADL nor QBTS has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

CADL vs. QBTS - Drawdown Comparison

The maximum CADL drawdown since its inception was -94.33%, roughly equal to the maximum QBTS drawdown of -96.67%. Use the drawdown chart below to compare losses from any high point for CADL and QBTS.

Drawdown Indicators

	CADL	QBTS	Difference
Max Drawdown Largest peak-to-trough decline	-94.33%	-96.67%	+2.34%
Max Drawdown (1Y) Largest decline over 1 year	-37.04%	-71.01%	+33.97%
Current Drawdown Current decline from peak	-65.00%	-67.78%	+2.78%
Average Drawdown Average peak-to-trough decline	-63.27%	-66.49%	+3.22%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.47%	33.60%	-13.13%

Volatility

CADL vs. QBTS - Volatility Comparison

The current volatility for Candel Therapeutics, Inc. (CADL) is 18.36%, while D-Wave Quantum Inc (QBTS) has a volatility of 20.29%. This indicates that CADL experiences smaller price fluctuations and is considered to be less risky than QBTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CADL	QBTS	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.36%	20.29%	-1.93%
Volatility (6M) Calculated over the trailing 6-month period	49.60%	77.91%	-28.31%
Volatility (1Y) Calculated over the trailing 1-year period	71.34%	117.60%	-46.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	169.43%	152.02%	+17.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	169.43%	152.02%	+17.41%

Financials